Join the club for FREE to access the whole archive and other member benefits.

Fountain Therapeutics

Biopharmaceutical company

At Fountain Therapeutics, we have combined the expertise of leaders in aging research and computation to build a pipeline of therapeutics aimed at reversing cellular aging. Our mission is to decouple aging from disease and significantly extend human health span.

Our AI-driven platform extracts previously hidden cellular features to measure aging with remarkable precision. This has enabled us to generate unprecedented insights into the cellular aging process. We have united science, medicine and engineering to turn these insights and technologies into a powerful drug discovery and development engine for the treatment of age-related diseases.


Visit website: https://fountaintx.com/

 fountaintx

Details last updated 29-May-2020

People at Fountain Therapeutics

Brian Hodge

Scientist at Fountain Therapeutics working on aging and age-related disease

John Dimos

CEO, Fountain Therapeutics

Fountain Therapeutics News

Fountain secured $6 million Series A-1 financing from Khosla Ventures

Fountain secured $6 million Series A-1 financing from Khosla Ventures

GlobeNewswire - 19-May-2020

With a total of $11 million, more in vivo preclinical drug testing to be expected